Literature DB >> 12886261

Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.

M A van der Pol, N Feller, G J Ossenkoppele, G W D Weijers, A H Westra, A van Stijn, H J Broxterman, G J Schuurhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12886261     DOI： 10.1038/sj.leu.2403025

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.

Authors:  Corine J Hess; Nicole Feller; Fedor Denkers; Angèle Kelder; Pauline A Merle; Michael C Heinrich; Amy Harlow; Johannes Berkhof; Gert J Ossenkoppele; Quinten Waisfisz; Gerrit J Schuurhuis
Journal:  Haematologica       Date:  2008-11-27       Impact factor: 9.941

Review 2.  New approaches for the detection of minimal residual disease in acute myeloid leukemia.

Authors:  Anna van Rhenen; Bijan Moshaver; Gert J Ossenkoppele; Gerrit Jan Schuurhuis
Journal:  Curr Hematol Malig Rep       Date:  2007-05       Impact factor: 3.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.